Literature DB >> 2613466

On the relation between citrate and calcium in normal and stone-former subjects.

A Conte1, P Roca, M Gianotti, F Grases.   

Abstract

The aim of this work is to evaluate citrate in a group of patients with calcium oxalate urolithiasis and in a control group for detecting possible differences between the two groups. The mean urinary concentration in groups of stone-formers was found significantly lower than in the control group. Particularly interesting was the correlation study between citrate and calcium. It was found that patients with hypocitraturia have hypercalciuria. Thus, it is particularly interesting to point out the importance of citrate in preventing the risk of lithiasis in stone-formers studied by us.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2613466     DOI： 10.1007/bf02559631

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


  17 in total

1.  Urinary citrate excretion in stone-formers and normal controls.

Authors:  S G Welshman; M G McGeown
Journal:  Br J Urol       Date:  1976-02

2.  THE RELATION OF URINARY CITRIC ACID EXCRETION TO THE MENSTRUAL CYCLE AND THE STEROIDAL REPRODUCTIVE HORMONES.

Authors:  E Shorr; A R Bernheim; H Taussky
Journal:  Science       Date:  1942-06-12       Impact factor: 47.728

3.  A quantitative investigation of the effects on the growth of calcium oxalate crystals on potential inhibitors.

Authors:  S G Welshman; M G McGeown
Journal:  Br J Urol       Date:  1972-12

4.  The urinary excretion of citric, hippuric, and lactic acid in normal adults and in patients with calcium oxalate urinary calculus disease.

Authors:  J S Elliot; M E Ribeiro
Journal:  Invest Urol       Date:  1972-07

5.  Activity products in stone-forming and non-stone-forming urine.

Authors:  W G Robertson; M Peacock; B E Nordin
Journal:  Clin Sci       Date:  1968-06       Impact factor: 6.124

6.  Determination of citrate in urine by simple direct photometry.

Authors:  A Millán; A Conte; A García-Raso; F Grases
Journal:  Clin Chem       Date:  1987-07       Impact factor: 8.327

7.  Variations in the activity of urinary inhibitors in calcium oxalate urolithiasis.

Authors:  F Grases; C Genestar; P March; A Conte
Journal:  Br J Urol       Date:  1988-12

8.  Urinary citrate excretion in patients with renal calculi.

Authors:  M Menon; C J Mahle
Journal:  J Urol       Date:  1983-06       Impact factor: 7.450

9.  Risk factors in calcium stone disease of the urinary tract.

Authors:  W G Robertson; M Peacock; P J Heyburn; D H Marshall; P B Clark
Journal:  Br J Urol       Date:  1978-12

10.  Citrate in daily and fasting urine: results of controls, patients with recurrent idiopathic calcium urolithiasis, and primary hyperparathyroidism.

Authors:  P O Schwille; D Scholz; M Paulus; W Engelhardt; A Sigel
Journal:  Invest Urol       Date:  1979-05
View more
  4 in total

1.  The origin and causes of struvite stones.

Authors:  A Garcia-Raia; A Conte; F Grases
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

2.  Hypocitraturia: a risk factor for reduced bone mineral density in idiopathic hypercalciuria?

Authors:  Maria-Goretti Moreira Guimarães Penido; Eleonora Moreira Lima; Marcelo Ferraz Oliveira Souto; Viviane Santuari Parizotto Marino; Ana-Luiza Fialho Tupinambá; Anderson França
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

3.  Sensing of mammalian IL-17A regulates fungal adaptation and virulence.

Authors:  Teresa Zelante; Rossana G Iannitti; Antonella De Luca; Javier Arroyo; Noelia Blanco; Giuseppe Servillo; Dominique Sanglard; Utz Reichard; Glen E Palmer; Jean-Paul Latgè; Paolo Puccetti; Luigina Romani
Journal:  Nat Commun       Date:  2012-02-21       Impact factor: 14.919

4.  Model-Based Assessment of Plasma Citrate Flux Into the Liver: Implications for NaCT as a Therapeutic Target.

Authors:  Z Li; D M Erion; T S Maurer
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-03-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.